Internet-Delivered Psychological Treatment for Cancer Survivors

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorKarolinska Institutet

About this trial

Negative psychological effects of cancer are common, but cancer survivors are rarely offered structured psychological treatment. Internet-delivered treatments have shown some promise, but specific treatment components have not been empirically evaluated which means that it is not clear which therapies that should be prioritized. In this randomized factorial trial at Karolinska Institutet, Stockholm, Sweden, 400 cancer survivors with psychiatric symptoms are enrolled in variations on a 10-week therapist-guided online psychological treatment intended to address the negative psychological long-term effects of cancer. The aim is to determine the contribution of treatment components to the overall effect.

Eligibility criteria

Qualifiers

Cancer survivor at least 0.5 years after main therapy

Clinically significant anxiety or depression (Patient Health Questionnaire 9 [PHQ-9]≥10, or Generalized Anxiety Disorder 7 [GAD-7]≥8, or 9-item Fear of Cancer Recurrence Inventory [FCRI-9]≥16)

At least 18 years old

Resident of Region Stockholms, Västra Götalandsregionen, or Region Skåne, Sweden (listed and de facto)

Disqualifiers

Recurrent thoughts of suicide, as based on clinical judgement aided by the structured interview and the self-report version of the Montgomery-Åsberg Depression Rating Scale (MADRS-S) item 9

Severe medical condition (e.g., very poor prognosis, stage IV cancer), severe psychiatric disorder (e.g., psychotic disorder, bipolar disorder, or severely debilitating substance use disorder, severe depression), or medical treatment (e.g., chemotherapy, immunotherapy, radiotherapy) that makes the treatment unfeasible

Other ongoing psychological treatment

Continuous psychotropic medication not stable for the past 4 weeks, or not expected to remain stable during the treatment period

Trial design

Treatments tested in this trial

  • Support and information
  • Behavioral activation
  • Systematic exposure with mindfulness training
  • Promotion of health behaviors

Treatment groups

400 Participants
are divided into 8 treatment groups

8

Treatment groups

See each treatment group below.

Sponsors and collaborators

Karolinska Institutet

Lead sponsor

Region Stockholm

Collaborator